Clinical Trials · NCT03634137
Implant Pharmacokinetic and Pharmacodynamic Study
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Clinuvel Pharmaceuticals Limited
- Enrollment
- 24
- Start date
- Sep 2009
- Locations
- 1 site, United States
- Primary endpoint
- Change in skin melanin density